Logo image of CMT

CORE MOLDING TECHNOLOGIES IN (CMT) Stock Fundamental Analysis

USA - NYSEARCA:CMT - US2186831002 - Common Stock

18.88 USD
-0.47 (-2.43%)
Last: 10/3/2025, 8:04:03 PM
18.51 USD
-0.37 (-1.96%)
After Hours: 10/3/2025, 8:04:03 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CMT. CMT was compared to 83 industry peers in the Chemicals industry. While CMT has a great health rating, its profitability is only average at the moment. CMT is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CMT had positive earnings in the past year.
CMT had a positive operating cash flow in the past year.
In the past 5 years CMT has always been profitable.
CMT had a positive operating cash flow in each of the past 5 years.
CMT Yearly Net Income VS EBIT VS OCF VS FCFCMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.25%, CMT is in the better half of the industry, outperforming 77.11% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.10%, CMT is in the better half of the industry, outperforming 67.47% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.81%, CMT is in the better half of the industry, outperforming 66.27% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CMT is above the industry average of 6.34%.
Industry RankSector Rank
ROA 4.25%
ROE 6.1%
ROIC 5.81%
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
CMT Yearly ROA, ROE, ROICCMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

CMT has a Profit Margin of 3.39%. This is in the better half of the industry: CMT outperforms 61.45% of its industry peers.
CMT's Profit Margin has improved in the last couple of years.
The Operating Margin of CMT (4.89%) is worse than 63.86% of its industry peers.
In the last couple of years the Operating Margin of CMT has grown nicely.
With a Gross Margin value of 17.50%, CMT is not doing good in the industry: 71.08% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CMT has grown nicely.
Industry RankSector Rank
OM 4.89%
PM (TTM) 3.39%
GM 17.5%
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
CMT Yearly Profit, Operating, Gross MarginsCMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CMT is still creating some value.
The number of shares outstanding for CMT has been reduced compared to 1 year ago.
CMT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CMT has been reduced compared to a year ago.
CMT Yearly Shares OutstandingCMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CMT Yearly Total Debt VS Total AssetsCMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

CMT has an Altman-Z score of 4.26. This indicates that CMT is financially healthy and has little risk of bankruptcy at the moment.
CMT has a better Altman-Z score (4.26) than 89.16% of its industry peers.
The Debt to FCF ratio of CMT is 1.62, which is an excellent value as it means it would take CMT, only 1.62 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.62, CMT belongs to the best of the industry, outperforming 92.77% of the companies in the same industry.
A Debt/Equity ratio of 0.12 indicates that CMT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.12, CMT belongs to the top of the industry, outperforming 89.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.62
Altman-Z 4.26
ROIC/WACC0.67
WACC8.71%
CMT Yearly LT Debt VS Equity VS FCFCMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.85 indicates that CMT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.85, CMT belongs to the top of the industry, outperforming 80.72% of the companies in the same industry.
A Quick Ratio of 2.36 indicates that CMT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.36, CMT belongs to the top of the industry, outperforming 84.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.85
Quick Ratio 2.36
CMT Yearly Current Assets VS Current LiabilitesCMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

2

3. Growth

3.1 Past

CMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.18%.
Measured over the past years, CMT shows a very strong growth in Earnings Per Share. The EPS has been growing by 40.08% on average per year.
CMT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.64%.
Measured over the past years, CMT shows a small growth in Revenue. The Revenue has been growing by 1.24% on average per year.
EPS 1Y (TTM)-39.18%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-27.4%
Revenue 1Y (TTM)-15.64%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-10.71%

3.2 Future

CMT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.66% yearly.
The Revenue is expected to decrease by -1.74% on average over the next years.
EPS Next Y-8.97%
EPS Next 2Y5.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-9.27%
Revenue Next 2Y-1.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CMT Yearly Revenue VS EstimatesCMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CMT Yearly EPS VS EstimatesCMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2022 2023 2024 2025 2026 2 4 6 8 10

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.00 indicates a correct valuation of CMT.
Based on the Price/Earnings ratio, CMT is valued a bit cheaper than 66.27% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.86, CMT is valued a bit cheaper.
The Price/Forward Earnings ratio is 11.13, which indicates a very decent valuation of CMT.
CMT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CMT is cheaper than 75.90% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, CMT is valued rather cheaply.
Industry RankSector Rank
PE 16
Fwd PE 11.13
CMT Price Earnings VS Forward Price EarningsCMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CMT is valued cheaper than 90.36% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CMT indicates a rather cheap valuation: CMT is cheaper than 84.34% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.73
EV/EBITDA 5.38
CMT Per share dataCMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

CMT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.66%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORE MOLDING TECHNOLOGIES IN

NYSEARCA:CMT (10/3/2025, 8:04:03 PM)

After market: 18.51 -0.37 (-1.96%)

18.88

-0.47 (-2.43%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03
Inst Owners76.46%
Inst Owner Change4.31%
Ins Owners5.34%
Ins Owner Change-9.23%
Market Cap161.61M
Analysts80
Price Target22.44 (18.86%)
Short Float %2.43%
Short Ratio6.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.54%
Min EPS beat(2)-12.99%
Max EPS beat(2)14.08%
EPS beat(4)2
Avg EPS beat(4)-10.99%
Min EPS beat(4)-100%
Max EPS beat(4)54.97%
EPS beat(8)5
Avg EPS beat(8)49.77%
EPS beat(12)8
Avg EPS beat(12)73.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.58%
Min Revenue beat(2)-11.13%
Max Revenue beat(2)3.97%
Revenue beat(4)3
Avg Revenue beat(4)-0.23%
Min Revenue beat(4)-11.13%
Max Revenue beat(4)5.25%
Revenue beat(8)5
Avg Revenue beat(8)0.53%
Revenue beat(12)8
Avg Revenue beat(12)3.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-20.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.44%
Valuation
Industry RankSector Rank
PE 16
Fwd PE 11.13
P/S 0.59
P/FCF 12.73
P/OCF 6.79
P/B 1.05
P/tB 1.22
EV/EBITDA 5.38
EPS(TTM)1.18
EY6.25%
EPS(NY)1.7
Fwd EY8.99%
FCF(TTM)1.48
FCFY7.86%
OCF(TTM)2.78
OCFY14.73%
SpS32.26
BVpS17.93
TBVpS15.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 6.1%
ROCE 7.49%
ROIC 5.81%
ROICexc 7.64%
ROICexgc 9.05%
OM 4.89%
PM (TTM) 3.39%
GM 17.5%
FCFM 4.6%
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
ROICexc(3y)11.4%
ROICexc(5y)9.43%
ROICexgc(3y)13.69%
ROICexgc(5y)11.53%
ROCE(3y)12.62%
ROCE(5y)10.78%
ROICexcg growth 3Y14.36%
ROICexcg growth 5YN/A
ROICexc growth 3Y16.49%
ROICexc growth 5YN/A
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
F-Score7
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.62
Debt/EBITDA 0.71
Cap/Depr 85.03%
Cap/Sales 4.02%
Interest Coverage 12.8
Cash Conversion 89.59%
Profit Quality 135.69%
Current Ratio 2.85
Quick Ratio 2.36
Altman-Z 4.26
F-Score7
WACC8.71%
ROIC/WACC0.67
Cap/Depr(3y)98.69%
Cap/Depr(5y)85.45%
Cap/Sales(3y)3.58%
Cap/Sales(5y)3.23%
Profit Quality(3y)108.24%
Profit Quality(5y)132.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-39.18%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-27.4%
EPS Next Y-8.97%
EPS Next 2Y5.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.64%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-10.71%
Revenue Next Year-9.27%
Revenue Next 2Y-1.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.48%
EBIT growth 3Y17.56%
EBIT growth 5YN/A
EBIT Next Year95.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.49%
FCF growth 3Y189.18%
FCF growth 5Y20.65%
OCF growth 1Y-31.88%
OCF growth 3Y40.98%
OCF growth 5Y16.05%